Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 80.9894 | 72 |
GSM780708 | Untreated after 4 days (C2_1) | 79.9506 | 72 |
GSM780709 | Untreated after 4 days (C3_1) | 84.7267 | 73 |
GSM780719 | Untreated after 4 days (C1_2) | 91.5244 | 74 |
GSM780720 | Untreated after 4 days (C2_2) | 80.9522 | 72 |
GSM780721 | Untreated after 4 days (C3_2) | 93.0536 | 74 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 87.3525 | 73 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 85.6392 | 73 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 87.4416 | 73 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 84.3217 | 73 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 101.418 | 75 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 96.2121 | 75 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 96.4116 | 75 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 83.7624 | 72 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 87.0334 | 73 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 87.9951 | 73 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 82.9176 | 72 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 84.5462 | 73 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 134.926 | 79 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 91.6538 | 74 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 85.7654 | 73 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 112.61 | 77 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 99.5908 | 75 |